Nifedipine (Procardia): Uses, MOA, Warnings

What is nifedipine?

Nifedipine is an active ingredient used in the treatment of angina, Raynaud’s syndrome, and high blood pressure (HBP).

In the United States, the original content lists the following brand names: Procardia, Adalat, Procardia XL, and Nifedical XL.

How nifedipine works

Nifedipine works by inhibiting the flow of calcium ions into myocardial tissue and the smooth muscle of the coronary arteries and peripheral vessels.

In practical terms, this action helps explain why it is used in conditions involving blood vessel narrowing or increased vascular tone.

Therapeutic uses listed in the original content

• Chronic stable angina pectoris, in combination treatment
• Vasospastic angina pectoris
• Raynaud’s syndrome
• High blood pressure

Dosage forms mentioned in the original content

The original text refers to several oral formulations, including rapid-release capsules, modified-release tablets, and prolonged-release OROS tablets. The exact product and release type matter because instructions are not the same for every formulation.

How nifedipine is taken

The original content states that nifedipine is taken by mouth and can be administered independently of meals.

Food may slow absorption, but it does not reduce absorption. The original content also advises avoiding grapefruit juice.

Because release type matters, the tablet or capsule should be swallowed whole and not chewed or broken when the product instructions say so.

Contraindications listed in the original content

• Hypersensitivity to nifedipine
• Cardiovascular shock
• Concomitant use with rifampicin
• OROS form: do not use in ileostomy after proctolectomy
• Rapid-release nifedipine: contraindicated in unstable angina and within 4 weeks of myocardial infarction

Warnings and precautions

The original content highlights several situations that require caution and medical supervision.

• Liver failure: dose reduction may be necessary
• Kidney failure: caution is advised
• Severe hypotension
• Manifest heart failure
• Severe aortic stenosis
• Diabetes
• Dialysis patients with malignant high blood pressure and irreversible renal failure, or hypovolemia
• Depressed ventricular function, due to increased risk of heart failure
• Advanced age, severe cerebrovascular disease, or benign prostatic hyperplasia, where low starting doses are mentioned for some formulations
• History of gastrointestinal stenosis for OROS tablets

The original content also notes that blood pressure monitoring is important and that treatment should be reduced gradually if it is being stopped.

It further states that nifedipine is not recommended in children and adolescents under 18 years.

Interactions mentioned in the original content

Nifedipine may interact with other medicines and substances. The original content specifically mentions the following:

• Increased nifedipine levels: CYP3A4 inhibitors such as erythromycin, ritonavir, ketoconazole, fluoxetine, nefazodone, quinupristine/dalfopristine, valproic acid, cimetidine, grapefruit juice, and cisapride
• Reduced nifedipine levels: CYP3A4 inducers such as phenobarbital, carbamazepine, phenytoin, and rifampicin
• Stronger blood-pressure-lowering effect: diuretics, beta-blockers, ACE inhibitors, angiotensin II receptor antagonists, other calcium antagonists, alpha-adrenergic blockers, PDE5 inhibitors, and alpha-methyldopa
• Increased digoxin toxicity
• Reduced quinidine levels
• Possible laboratory test interference: spectrophotometric determination of vanillylmandelic acid in urine

If you take other prescription medicines, over-the-counter products, or herbal supplements, the safest step is to verify interactions with a pharmacist or the official product leaflet.

Pregnancy and breastfeeding

Pregnancy

The original content says nifedipine should not be used during pregnancy unless the clinical situation requires treatment with this active ingredient. It also states that it should be reserved for women with severe high blood pressure who do not respond to standard treatment.

Breastfeeding

Nifedipine is excreted in breast milk, and the original content says the concentration in milk is almost comparable to the mother’s serum concentration.

For immediate-release formulations, the original content suggests delaying lactation or milk extraction until 3 to 4 hours after administration to reduce exposure in the baby.

Driving and operating machinery

The original content warns that nifedipine can limit reaction ability, especially at the beginning of treatment. Caution is advised when driving or using dangerous machinery.

The risk may be greater if alcohol is taken at the same time.

Possible adverse reactions listed in the original content

• Headache
• Dizziness
• Edema
• Vasodilatation
• Constipation
• Feeling unwell

Safety reminder

Before using any nifedipine product, check the exact formulation, strength, and instructions on the package leaflet or official medication guide. Do not assume that all nifedipine products are taken the same way, because release type can change how the medicine should be used.

If you have chest pain, very low blood pressure symptoms, severe dizziness, or any unexpected reaction, seek urgent medical advice.

Frequently asked questions

Sources and reference suggestions

The original content cites FDA and USP-based ingredient information. For product-specific details, the most useful references are the official medication guide and trusted drug information databases.

Video reference from the original content: Nifedipine/Procardia video